Indeed, genome-wide association studies identified a single nucleotide polymorphism (SNP) in the TNFRSF1A gene coding for TNFR1 that is associated with MS but not with other autoimmune diseases, where anti-TNF therapy is working. This evidence concerns the gene TNFRSF1A and myeloid sarcoma.